Abstract A23: SMYD3 links methylation of MAP3K2 to Ras-driven tumors
Paweł K. Mazur(The University of Texas MD Anderson Cancer Center), Julien Sage(Stanford University), Alex W. Wilkinson(Stanford University), Benjamin A. Garcia(Washington University in St. Louis), Atul J. Butte(University of California, San Francisco), Nicolas Reynoird(Centre National de la Recherche Scientifique), Michael J. Huddleston(GlaxoSmithKline (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Pascal W.T.C. Jansen(Radboud University Nijmegen), Michiel Vermeulen(Radboud University Nijmegen), Purvesh Khatri(Stanford University), Glenn S. Van Aller(GlaxoSmithKline (United Kingdom)), Ryan G. Kruger(Arysta LifeScience (France)), Olena Barbash(GlaxoSmithKline (United States)), Or Gozani(Stanford University), Shichong Liu(University of Pennsylvania)
Cited by 0
Related Papers
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
|Science Signaling|2010|1.5k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k